Publications in collaboration with researchers from Tokyo Medical University Hachioji Medical Center (1)

2023

  1. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

    Japanese Journal of Ophthalmology, Vol. 67, Núm. 3, pp. 264-279